Aplagon doses first patient in phase 2a trial of APAC with peripheral arterial occlusive disease/chronic limb threatening ischemia: Helsinki, Finland Saturday, March 14, 2026, 18: ...
Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...
Greenwood Leflore Hospital welcomed doctors from Guatemala last week to provide education and training that will help save ...
For decades, the United States has grappled with the complexities of chronic kidney disease and the plight of the almost ...
Background Vascular access (VA) is a critical component of hemodialysis (HD). Arteriovenous fistulas (AVFs) are associated with lower morbidity and mortality compared to central venous catheters (CVCs ...
Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System. The St. Louis-based company also picked up Category B assignment from the Centers for ...
The cost of emergency dialysis is estimated to be eight times that of in-center dialysis. A new study reveals that a transitional dialysis program piloted in Travis County (Austin, Texas) resulted in ...
The cost of emergency dialysis is estimated to be eight times that of in-center dialysis. A new study reveals that a transitional dialysis program piloted in Travis County (Austin, Texas) resulted in ...
SOUTH JORDAN, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (MMSI), a global leader of healthcare technology, today announced positive findings from the randomized AVF arm of the ...
October 8, 2025—Cagent Vascular announced the United States commercial launch of 7- and 8-mm diameters of the Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter. The ...
ABSTRACT: Introduction: The arteriovenous fistula (AVF) is the vascular approach of choice for chronic hemodialysis, due to its durability and low morbidity and mortality. However, it remains exposed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results